Nouvelles

2020


Octobre 2020

Stannous DISIDA kits 

The Calgary Radiopharmaceutical Centre (CRC) has Stannous DISIDA kits available for distribution to Nuclear Medicine departments performing hepatobiliary imaging. It is offered to help mitigate the interim shortage of Mebrofenin kits in Canada and is Health Canada approved.


Septembre 2020

Stannous DISIDA kits 

The Calgary Radiopharmaceutical Centre (CRC) has Stannous DISIDA kits available for distribution to Nuclear Medicine departments performing hepatobiliary imaging. It is offered to help mitigate the interim shortage of Mebrofenin kits in Canada and is Health Canada approved.

*************************

Avril 2020


Air Transport Improves for Medical Radioisotopes

International air transport has been the main bottleneck in getting radioisotopes and nuclear medicines where they are needed during the COVID-19 pandemic, but Nuclear Medicine Europe (NMEu) says there are signs the situation is improving.  -  Read more


*************************


CANM Guidelines for Imaging of the Dopamine Transport System in Evaluation of Movement Disorders

INTRODUCTION - The Canadian Association of Nuclear Medicine (CANM) strives for excellence in the practice of diagnostic and therapeutic nuclear medicine by promoting the continued professional competence of nuclear medicine specialists, establishing guidelines of clinical practice, and encouraging biomedical research. We work with all professionals in nuclear medicine to ensure that Canadians have access to the highest quality nuclear medicine services. -- Read more 


*************************

BELNUC - Recommendations for performing V/Q scans in the context of COVID-19  (disponible en anglais seulement)

The Bottom Line

Substituting ventilation scintigraphy by CT as part of stand-alone perfusion SPECT/CT is not recommended, as this reduces the specificity of the study. Both perfusion and ventilation studies should be performed to rule out pulmonary embolism.   Based on recommendations by the French Society of Nuclear Medicine (SFMN) and the German Nuclear Medicine Society (DGN).

Read more here!


*************************


Vous trouverez ci-bas une mise à jour sur les mesures prises par Jubilant Radiopharma durant la pandémie

Information:  Cliquez ici

*************************


Communitcation From the NMEu Emergency Response Team (ERT) - April 6, 2020

COVID-19 and the Global Supply of Mo-99 & Other Isotopes

The Security of Supply Working Group (SoS WG) Emergency Response Team (ERT) held a teleconference on 6 April 2020 to discuss the impact of the COVID-19 pandemic on Mo-99 and other radioisotope production.  -  Read here


*************************

Communitcation From the NMEu Emergency Response Team (ERT) - March 30, 2020

COVID-19 and the Global Supply of Mo-99 & Other Isotopes

The Security of Supply Working Group (SoS WG) Emergency Response Team (ERT) held a teleconference on 30 March to discuss the impact of the COVID-19 pandemic on Mo-99 and other radioisotope production.  -  Read here


************************* 


GROUPE DE TRAVAIL SFMN Explorations Pulmonaires ventilatoires et perfusionnelles

Recommandations pour la réalisation de la scintigraphie pulmonaire dans le contexte d’épidémie due au virus Covid-19

Lire ici


*************************

Lantheus

Un message de Lantheus Imagerie Médicale concernant Coronavirus (la COVID-19  -  lire ici

*************************

Mars 2020

Cyclomedica

INFORMATION IMPORTANTE ! Technegas & Technegas Plus (Cyclomedica Canada) (FR) - lire ici

Tgas and COVID - réponses (FR) - lire ici
Tgas and COVID Response (ANG) - lire ici

Cyclomedica's Statement Regarding Aerosol Generating Procedures (ANG) - lire ici

Technegas and COVID-19 - Corp Letter (ANG) - lire ici 


*************************

Advanced Accelerator Applications (AAA)

NETSPOTMD - Homologation par Santé Canada et disponibilité - Trousse pour la préparation d’oxodotréotide de gallium (68Ga) pour injection


C’est avec plaisir qu’Advanced Accelerator Applications S.A. (AAA), une société détenue par Novartis, annonce l’homologation de NETSPOTMD (trousse pour la préparation d’oxodotréotide de gallium [68Ga] pour injection) par Santé Canada.

*************************

Isologic

COVID-19 : Informations de la part d'ISOLOGIC


Alors que les autorites de sante publique deploient des mesures pour limiter la propagation de la COVID- 19, nous vous informons qu'ISOLOGIC suit de tres pres I'evolution de la situation et que nous agissons au sein de nos sites de production afin de proteger et soutenir nos clients et nos employes. Nos objectifs sont de reduire les risques de propagation des maladies contagieuses et de maintenir nos activites.

*************************

2019

Novembre 2019

Availability of Stannous PYP Kit

The Calgary Radiopharmaceutical Centre (CRC) holds a Drug Establishment Licence and produces a few niche radiopharmaceutical products. At this time the CRC is the only supplier in Canada of a stannous pyrophosphate kit (Stannous PYP Kit) for the preparation of Technetium Tc99m pyrophosphate.

           Information Letter

           Order Form

           Product Package Insert


*************************

Mars 2019

European School of Medical Imaging Technology (ESMIT)


Because the CANM is an affiliate member of the EANM, our members are given access to the highly regarded European School of Medical Imaging Technology (ESMIT). The European Nuclear Medicine practice is dynamic and has much experience with many procedures which are now finding their way to Canada. As well, they offer perspectives on established practice.

https://www.eanm.org/esmit/


*************************


Availability of Choletec™ (Mebrofenin) – Kit For The Preparation of Technetium Tc-99

BRACCO IMAGING Canada is pleased to inform you that a new lot of Canadian Choletec™ (Mebrofenin) was received at our Montreal facility. We immediately shipped and fulfilled the request for products to Canadian facilities who had an order with BRACCO.

  • BRACCO IMAGING Canada Letter
*************************

Stannous DISIDA Kits by the Calgary Radiopharmaceutical Centre

Alberta Health Services

The Calgary Radiopharmaceutical Centre (CRC) has Stannous DISIDA Kits available for distribution to Nuclear Medicine departments performing hepatobiliary imaging. This product is being offered to the Nuclear Medicine community-at-large to help mitigate the interim shortage of DISIDA and Mebrofenin kits in Canada.

*************************

2018

Octobre 2018

Quality Control in the Production of Radiopharmaceuticals


Advances have led to the production of new radiopharmaceuticals and availability of new production routes. Various new diagnostic agents in the field (such as Ga-68 radiopharmaceuticals and generators) as well as therapeutic agents (such as alpha emitters) have been added to the clinician’s menu. It is essential that radiopharmaceuticals are prepared within a robust quality control system encompassing materials and personnel, with adequate documentation, and continuous review of ongoing results. This publication provides guidelines and best practices for the quality control of medical radioisotopes and radiopharmaceuticals. It was written by a group of experts with experience across a range of radiopharmaceuticals and is intended to support professionals in the preparation of good quality and safe products to be used in nuclear medicine procedures.


Juin 2018

Darlington to supply moly-99


Ontario Power Generation's (OPG) Darlington nuclear power plant is to produce molybdenum-99 (Mo-99) for use in new technetium-99m (Tc-99m) generators designed by BWX Technologies Inc. The Candu plant will be the first large-scale commercial nuclear power plant in the world to produce Mo-99.

http://www.world-nuclear-news.org/RS-Darlington-to-supply-molybdenum-99-2106187.html


Avril 2018

Mo-99 Production Activities at NTP Radioisotopes (NTP) and I-131 Supply Situation


NTP reported that it received approval from the South African Nuclear Regulator to return to normal operations through the end of June 2018. During this period, NTP will engage with the NNR to ensure continued normal operation from July 2018 onwards. NTP also stated that as a result of this approval, NTP will be in a position to manufacture I-131 to assist with the international shortage.


Mars 2018

Récipiendaire du prix Émérite 2018 

Dr John Powe, Vancouver / 

Récipiendaire du prix Eric Lepp 2018

Dre Caroline Malo Pion, Montréal


2017

Octobre 2018

Quality Control in the Production of Radiopharmaceuticals
Advances have led to the production of new radiopharmaceuticals and availability of new production routes. Various new diagnostic agents in the field (such as Ga-68 radiopharmaceuticals and generators) as well as therapeutic agents (such as alpha emitters) have been added to the clinician’s menu. It is essential that radiopharmaceuticals are prepared within a robust quality control system encompassing materials and personnel, with adequate documentation, and continuous review of ongoing results. This publication provides guidelines and best practices for the quality control of medical radioisotopes and radiopharmaceuticals. It was written by a group of experts with experience across a range of radiopharmaceuticals and is intended to support professionals in the preparation of good quality and safe products to be used in nuclear medicine procedures.


Juin 2018

Darlington to supply moly-99

Ontario Power Generation's (OPG) Darlington nuclear power plant is to produce molybdenum-99 (Mo-99) for use in new technetium-99m (Tc-99m) generators designed by BWX Technologies Inc. The Candu plant will be the first large-scale commercial nuclear power plant in the world to produce Mo-99.

http://www.world-nuclear-news.org/RS-Darlington-to-supply-molybdenum-99-2106187.html


Avril 2018

Mo-99 Production Activities at NTP Radioisotopes (NTP) and I-131 Supply Situation

NTP reported that it received approval from the South African Nuclear Regulator to return to normal operations through the end of June 2018. During this period, NTP will engage with the NNR to ensure continued normal operation from July 2018 onwards. NTP also stated that as a result of this approval, NTP will be in a position to manufacture I-131 to assist with the international shortage.


Mars 2018

Récipiendaire du prix Émérite 2018 

Dr John Powe, Vancouver / 

Récipiendaire du prix Eric Lepp 2018

Dre Caroline Malo Pion, Montréal


Juillet 2017

Beta, BTG’s Education, Training and Audit program

Beta, BTG’s Education, Training and Audit program is designed to reduce the risk of radiation exposure when performing selective internal radiation therapy (SIRT) by increasing awareness of radiation safety and providing risk education.

For more information, click here:


IAEA Webinars and E-Learning Modules

Free IAEA Webinars and e-learning modules available

For more information, click here:



Mai 2017

Hermes - News Letter and Press Release

Introduction de notre nouveau PDG

Nous sommes ravis d’annoncer la nomination de Mikael Strindlund en tant que nouveau président et chef de la direction chez Hermes Solutions Médicales

Cliquez ici pour visionner l'info lettre.


***************************


2016

Novembre 2016


Un nouvel Accord sur la santé pour tous les Canadiens - Novembre 2016

Le rapport de la conférence - Les présentateurs et les débatteurs présents au Sommet sur la santé tenu par Canada 2020 ont formulé de nombreuses recommandations quant aux façons d’améliorer le système de santé au Canada.

Lire le rapport ici


*********************

Octobre 2016


Nos initiatives fructueuses en matière de chaîne d’approvisionnement nous ont permis de nous préparer pour la transition du réacteur national de recherche universel (NRU) à la réserve d’urgence du Mo-99 qui aura lieu le 31 octobre 2016

En Lire plus


*********************


Septembre 2016


Lettre de Lantheus concernant l'approvisionnemnt en Mo99 - 28 septembre 2016

Nos initiatives fructueuses en matière de chaîne d’approvisionnement nous ont permis de nous préparer pour la transition du réacteur national de recherche universel (NRU) à la réserve d’urgence du Mo-99 qui aura lieu le 31 octobre 2016. En collaborant étroitement avec nos fournisseurs ANSTO (Australie), IRE (Belgique) et NTP (Afrique du Sud), desquels nous obtenons déjà la plus grande partie de notre approvisionnement en Mo-99, nous avons prévu nos besoins quotidiens, hebdomadaires et mensuels en Mo-99. Nous participons régulièrement à des réunions pour examiner les besoins en approvisionnement à court et à long terme afin de coordonner notre chaîne d’approvisionnement équilibrée et diversifiée.

Lire la lettre en entier en cliquant ici.


*********************


GE Healthcare regrets to inform you that the expected return DMSA (Kit for the Preparation of Technetium Tc99m Succimer Injection) to the global market has been delayed indefinitely.  We will be unable to provide supply of DMSA to our customers until further notice.

En lire plus


*********************


Présidence - WFNMB-Presidency Bid Presidency Candidate:
Dr. Jean-Luc Urbain
En  lire plus

******************************************

Comments to USP Chapter 797-Compounding Radiopharmaceuticals-SNMMI
Read More
*********************

New seminars in the ‘Basic Nuclear Medicine’ series have been released. To access them please visit the IAEA Human Health Campus website or click on the title above. Be on the lookout for a new seminar every Monday in the Basic and Paediatric Nuclear Medicine Series.
Click Here
 

Nouvelles - archivées avant 2016

Notification Regarding Molybdenum-99 Supply Disruption from the NRU / Avis concernant une rupture d'approvisionnement de Molybdène-99 du réacteur NRU - November 23, 2013

In accordance with the Government of Canada protocol, Atomic Energy of Canada Limited (AECL) has advised Health Canada that the NRU has returned to service and resumed supplying molybdenum-99. 

Read More..., 


Avis concernant une rupture d'approvisionnement de Molybdène-99 du réacteur NRU - 23 novembre 2013

En Lire Plus.... 


CBC News - Isotope Supply - November 22, 2013
http://www.cbc.ca/news/health/medical-isotope-supply-interrupted-across-canada-1.2436964


Mise-à-jour - Approvisionnement en Mo-99 - Mallinckrodt
- 21 novembre 

Mallinckrodt Mo-99 Update 11-20-13 CN-FR.pdf

MISE À JOUR  - 19 novembre 2013 Avis concernant une rupture      d'approvisionnement de Molybdène-99 du réacteur NRU - Lettre du Dr.    Norman Laurin, Président de l’ACMN. 

MISE À JOUR  - 23 septembre 2013

Une lettre du Dr Norman Laurin en ce qui a trait à l'approvisionnement en MAA.

En lire plus…. 

Powered by Wild Apricot Membership Software